Workers with mental health conditions are twice as likely as those without to report unmet mental health needs.

Employer costs for GLP-1 agonists and similar drugs could end up averaging $3.17 to $22.88 per enrollee per month.

Anthem Blue's parent maintains in the complaint that underwriting expertise as crucial to its competitive edge.

As the legal and regulatory environment changes and employee expectations shift, employers face pressure to meet compliance requirements while offering competitive benefits,” according to the latest ...

This is according to a WTW analysis of the market, which found PRT is increasingly appealing to plan sponsors amid rising interest rates, favorable funding levels and a growing focus on de-risking.

According to the data, overall leaves of absence increased 30% between 2019 and 2024 with a staggering 300% increase when looking specifically at mental health-related leaves of absence.

The analysts assumed in illustrations for 2026 forecasts that a typical employer's stop-loss premiums will rise 11.5% next year. But "actual policyholder results will vary, with increases approaching ...

The U.S. Census Bureau's new American Community Survey tables show that employers in 10 states provided health coverage for fewer than 58% of the people ages 18 through 64 in those states. That ...

UnitedHealth Group has stepped up its lobbying efforts targeting the Trump administration as it seeks to rebound from numerous lawsuits and regulatory issues that have caused its market value to ...

This comes after the FTC issued a final rule to promote competition by banning noncompetes nationwide, which has since been challenged in federal court.

Plan sponsors view advisor value as a combination of service and cost, with their top priorities including improving participant outcomes, boosting employee satisfaction and optimizing plan design to ...

The total health benefit cost per employee is expected to rise an average of 6.5% next year, even after accounting for planned cost-reduction measures.